Frontiers in Oncology | Thoracic Oncology

Review

Published on 26 Jul 2018

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation

in Thoracic Oncology

Willem J. A. Witlox
Bram L. T. Ramaekers
Jaap D. Zindler
Daniëlle B. P. Eekers
Judith G. M. van Loon
Lizza E. L. Hendriks
Anne-Marie C. Dingemans
Dirk K. M. De Ruysscher

Frontiers in Oncology

doi 10.3389/fonc.2018.00241

6,542 views
22 citations

Original Research

Published on 24 Jul 2018

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

in Thoracic Oncology

Corey J. Langer
Edward S. Kim
Eric C. Anderson
Robert M. Jotte
Manuel Modiano
Daniel E. Haggstrom
Matei P. Socoteanu
David A. Smith
Christopher Dakhil
Kartik Konduri

Frontiers in Oncology

doi 10.3389/fonc.2018.00262

8,444 views
10 citations

Original Research

Published on 24 Jul 2018

nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

in Thoracic Oncology

Ajeet Gajra
Nagla Abdel Karim
Deborah A. Mulford
Liza Cosca Villaruz
Marc Ryan Matrana
Haythem Y. Ali
Edgardo S. Santos
Tymara Berry
Teng Jin Ong
Alexandra Sanford

Frontiers in Oncology

doi 10.3389/fonc.2018.00253

6,964 views
13 citations

Review

Published on 24 Jul 2018

Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

in Thoracic Oncology

Rachel Ryu
Kristina E. Ward

Frontiers in Oncology

doi 10.3389/fonc.2018.00277

17,114 views
27 citations

Review

Published on 03 Jul 2018

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

in Thoracic Oncology

William J. Kelly
Neil J. Shah
Deepa S. Subramaniam

Frontiers in Oncology

doi 10.3389/fonc.2018.00208

24,575 views
82 citations

Case Report

Published on 05 Jun 2018

Invasive Aspergillosis Mimicking Metastatic Lung Cancer

in Thoracic Oncology

Michiel J. E. G. W. Vanfleteren
Anne-Marie C. Dingemans
Veerle F. Surmont
Karim Y. Vermaelen
Alida A. Postma
Astrid M. L. Oude Lashof
Cordula C. M. Pitz
Lizza E. L. Hendriks

Frontiers in Oncology

doi 10.3389/fonc.2018.00188

15,439 views
19 citations

Case Report

Published on 22 May 2018

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification

in Thoracic Oncology

Arenda D. Meedendorp
Arja ter Elst
Nils A. ’t Hart
Harry J. M. Groen
Ed Schuuring
Anthonie J. van der Wekken

Frontiers in Oncology

doi 10.3389/fonc.2018.00176

4,488 views
5 citations

Review

Published on 11 May 2018

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis

in Thoracic Oncology

Rute M. S. M. Pedrosa
Dana A. M. Mustafa
Joachim G. J. V. Aerts
Johan M. Kros

Frontiers in Oncology

doi 10.3389/fonc.2018.00159

7,837 views
22 citations

Review

Published on 09 May 2018

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions

in Thoracic Oncology

Dianne Hartgerink
Britt van der Heijden
Dirk De Ruysscher
Alida Postma
Linda Ackermans
Ann Hoeben
Monique Anten
Philippe Lambin
Karin Terhaag
Arthur Jochems

Frontiers in Oncology

doi 10.3389/fonc.2018.00154

13,485 views
52 citations

Review

Published on 11 Apr 2018

Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment

in Thoracic Oncology

J. Remon
Benjamin Besse

Frontiers in Oncology

doi 10.3389/fonc.2018.00088

12,234 views
72 citations

Mini Review

Published on 10 Apr 2018

First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?

in Thoracic Oncology

Ajaz Bulbul
Hatim Husain

Frontiers in Oncology

doi 10.3389/fonc.2018.00094

13,744 views
26 citations

Original Research

Published on 23 Feb 2018

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression

in Thoracic Oncology

Kathrin Oehl
Jelena Kresoja-Rakic
Isabelle Opitz
Bart Vrugt
Walter Weder
Rolf Stahel
Peter Wild
Emanuela Felley-Bosco

Frontiers in Oncology

doi 10.3389/fonc.2018.00040

5,323 views
17 citations

Case Report

Published on 30 Jan 2018

A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass

in Thoracic Oncology

Serafeim Chrysikos
Maria Kaponi
Christina Triantafillidou
Theodoros Karampitsakos
Argyrios Tzouvelekis
Maria Anyfanti
Konstantinos Marossis
Marios Konstantinou
Rodoula Tringidou
Demosthenes Bouros

Frontiers in Oncology

doi 10.3389/fonc.2018.00011

3,175 views
6 citations

Editorial

Published on 13 Dec 2017

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine

in Thoracic Oncology

Barbara Melosky

Frontiers in Oncology

doi 10.3389/fonc.2017.00311

2,719 views
2 citations

Mini Review

Published on 29 Sep 2017

Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Alia Daoud
Quincy S. Chu

Frontiers in Oncology

doi 10.3389/fonc.2017.00222

4,697 views
6 citations

Clinical Trial

Published on 19 Sep 2017

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer

in Thoracic Oncology

Thierry Berghmans
Arnaud Scherpereel
Anne-Pascale Meert
Vicente Giner
Jacques Lecomte
Jean-Jacques Lafitte
Nathalie Leclercq
Marianne Paesmans
Jean-Paul Sculier
for the European Lung Cancer Working Party (ELCWP)

Frontiers in Oncology

doi 10.3389/fonc.2017.00217

4,763 views
9 citations

Review

Published on 01 Sep 2017

Smoking and Lung Cancer: A Geo-Regional Perspective

in Thoracic Oncology

Zahraa Rahal
Shaza El Nemr
Ansam Sinjab
Hassan Chami
Arafat Tfayli
Humam Kadara

Frontiers in Oncology

doi 10.3389/fonc.2017.00194

18,140 views
66 citations

Mini Review

Published on 28 Aug 2017

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

in Thoracic Oncology

Kentaro Inamura

Frontiers in Oncology

doi 10.3389/fonc.2017.00193

101,302 views
457 citations

Mini Review

Published on 13 Jun 2017

Low Grade Neuroendocrine Tumors of the Lung

in Thoracic Oncology

Barbara Melosky

Frontiers in Oncology

doi 10.3389/fonc.2017.00119

20,068 views
14 citations

Mini Review

Published on 31 May 2017

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

in Thoracic Oncology

Tristan A. Barnes
Grainne M. O’Kane
Mark David Vincent
Natasha B. Leighl

Frontiers in Oncology

doi 10.3389/fonc.2017.00113

15,626 views
56 citations

Original Research

Published on 30 May 2017

Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy

in Thoracic Oncology

Rohan Arora
Venkat Krishnan

Frontiers in Oncology

doi 10.3389/fonc.2017.00104

9,963 views
4 citations

Mini Review

Published on 16 May 2017

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib

in Thoracic Oncology

Sami Morin-Ben Abdallah
Vera Hirsh

Frontiers in Oncology

doi 10.3389/fonc.2017.00097

6,275 views
11 citations

Review

Published on 06 Apr 2017

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

in Thoracic Oncology

Marco A. J. Iafolla
Rosalyn A. Juergens

Frontiers in Oncology

doi 10.3389/fonc.2017.00067

8,483 views
26 citations

Mini Review

Published on 05 Apr 2017

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer

in Thoracic Oncology

Annick Wong

Frontiers in Oncology

doi 10.3389/fonc.2017.00033

7,009 views
16 citations

1,913 articles

articles

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

Invasive Aspergillosis Mimicking Metastatic Lung Cancer

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions

Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment

First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression

A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass

Editorial: Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine

Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer

Smoking and Lung Cancer: A Geo-Regional Perspective

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

Low Grade Neuroendocrine Tumors of the Lung

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer